CEO of Natera Inc (NTRA, Financial) Matthew Rabinowitz sold 732,831 shares of NTRA on 06/19/2016 at an average price of $11.94 a share. The total sale was $8,750,000.
Natera Inc is a diagnostics company with proprietary molecular and bioinformatics technology that it is deploying to change the management of genetic disease. Natera Inc has a market cap of $698.120 million; its shares were traded at around $13.62 with and P/S ratio of 2.61.
For the complete insider trading history of NTRA, click here.
Natera Inc is a diagnostics company with proprietary molecular and bioinformatics technology that it is deploying to change the management of genetic disease. Natera Inc has a market cap of $698.120 million; its shares were traded at around $13.62 with and P/S ratio of 2.61.
CEO Recent Trades:
- CEO Matthew Rabinowitz sold 732,831 shares of NTRA stock on 06/19/2016 at the average price of 11.94. Matthew Rabinowitz owns at least 2,210,385 shares after this. The price of the stock has increased by 14.07% since.
CFO Recent Trades:
- CFO Herm Rosenman sold 1,806 shares of NTRA stock on 06/02/2016 at the average price of 12.04. Herm Rosenman owns at least 7,530 shares after this. The price of the stock has increased by 13.12% since.
Directors and Officers Recent Trades:
- Director John Steuart bought 83,752 shares of NTRA stock on 06/19/2016 at the average price of 11.94. John Steuart owns at least 83,752 shares after this. The price of the stock has increased by 14.07% since.
- Director, 10% Owner Roelof Botha bought 837,521 shares of NTRA stock on 06/19/2016 at the average price of 11.94. Roelof Botha owns at least 8,581,981 shares after this. The price of the stock has increased by 14.07% since.
- Chief Technology Officer Jonathan Sheena sold 188,442 shares of NTRA stock on 06/19/2016 at the average price of 11.94. Jonathan Sheena owns at least 427,109 shares after this. The price of the stock has increased by 14.07% since.
For the complete insider trading history of NTRA, click here.
